Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Wei Yang
Affiliation
ORCID
Career Start Year
2002
Papers
132
H Index
54
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36646759
Fructose-1,6-bisphosphatase 1 dephosphorylates IκBα and suppresses colorectal tumorigenesis.
Cell Res
2023
37608772
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer
J Pathol
2023
37608771
Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol
2023
35347804
TOX3 regulates the proliferation and apoptosis of colorectal cancer by downregulating RhoB via the activation of the MAPK pathway.
Cell Biology International
2022
35048565
Pyruvate Facilitates FACT-Mediated γH2AX Loading to Chromatin and Promotes the Radiation Resistance of Glioblastoma.
Advanced Science
2022
35315437
MAPK signalling-induced phosphorylation and subcellular translocation of PDHE1α promotes tumour immune evasion.
Nature Metabolism
2022
34846643
Cancer metabolism and tumor microenvironment: fostering each other?
Science China Life Sciences
2022
34538550
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection.
Acad Radiol
2022
34720086
Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine.
J Clin Invest
2021
34179090
Sinomenine Suppresses Development of Hepatocellular Carcinoma Cells Inhibiting MARCH1 and AMPK/STAT3 Signaling Pathway.
Frontiers in Molecular Biosciences
2021
34066769
Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer.
Cancers
2021
32901841
lncRNA FEZF1â¿¿AS1 promotes migration, invasion and epithelialâ¿¿mesenchymal transition of retinoblastoma cells by targeting miRâ¿¿1236â¿¿3p.
Molecular Medicine Reports
2020
32129476
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
J Pathol
2020
30824700
Tyrosine phosphorylation activates 6-phosphogluconate dehydrogenase and promotes tumor growth and radiation resistance.
Nat Commun
2019
30638976
Burnout in Chairs of Academic Radiology Departments in the United States.
Academic Radiology
2019
31140101
BATF2 reverses multidrug resistance of human gastric cancer cells by suppressing Wnt/β-catenin signaling.
In Vitro Cellular and Developmental Biology - Animal
2019
31131189
TLR1/2 Specific Small-Molecule Agonist Suppresses Leukemia Cancer Cell Growth by Stimulating Cytotoxic T Lymphocytes.
Advanced Science
2019
31447391
α-Ketoglutarate-Activated NF-κB Signaling Promotes Compensatory Glucose Uptake and Brain Tumor Development.
Mol Cell
2019
31005169
Imaging features of triple-negative breast cancers according to androgen receptor status.
Eur J Radiol
2019
31243371
UDP-glucose accelerates SNAI1 mRNA decay and impairs lung cancer metastasis.
Nature
2019
31549215
BATF2 inhibits chemotherapy resistance by suppressing AP-1 in vincristine-resistant gastric cancer cells.
Cancer Chemotherapy and Pharmacology
2019
29374384
A phase II study of tipifarnib and gemcitabine in metastatic breast cancer.
Invest New Drugs
2018
28755879
Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer.
Clin Breast Cancer
2018
30029001
Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis.
Mol Cell
2018
30311036
A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β.
Invest New Drugs
2018
30248155
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
PLoS One
2018
30335765
Phosphoglucomutase 1 inhibits hepatocellular carcinoma progression by regulating glucose trafficking.
PLoS Biol
2018
29351852
EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis.
Mol Cell
2018
28035139
Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2.
Cell Res
2017
28507061
RNF8 mediates histone H3 ubiquitylation and promotes glycolysis and tumorigenesis.
Journal of Experimental Medicine
2017
28953868
Corrigendum: Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
Nature
2017
28341031
Surveillance of women with a personal history of breast cancer by tumour subtype.
Clinical Radiology
2017
29228698
Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis.
Oncotarget
2017
28135148
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.
J Clin Oncol
2017
27726422
Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision.
American Journal of Roentgenology
2016
26990854
Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.
Am J Surg Pathol
2016
26716893
Sclerostin Antibody Treatment Improves the Bone Phenotype of Crtap(-/-) Mice, a Model of Recessive Osteogenesis Imperfecta.
Journal of Bone and Mineral Research
2016
26942675
Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
Mol Cell
2016
27447749
miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells.
Oncotarget
2016
27485204
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis.
Nature Communications
2016
27116366
Confocal fluorescence microscopy to evaluate changes in adipocytes in the tumor microenvironment associated with invasive ductal carcinoma and ductal carcinoma in situ.
International Journal of Cancer
2016
27877089
Insights into the gene: A propeller for stemness in primitive stem cells.
International Journal of Biological Sciences
2016
23648437
Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.
Am J Clin Oncol
2015
25929765
Incidental primary breast cancer detected on PET-CT.
Breast Cancer Research and Treatment
2015
25287438
Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
Annals of Surgical Oncology
2015
25417171
Confocal fluorescence microscopy for rapid evaluation of invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies.
Breast Cancer Research and Treatment
2015
25779879
Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.
Molecular Genetics and Metabolism
2015
25821200
Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.
Stem Cells
2015
25773278
Structural basis of PKM2 regulation.
Protein and Cell
2015
25770102
Pyruvate kinase M2 at a glance.
Journal of Cell Science
2015
1 - 50 of 132
Column Actions
Search
Recommended Authors
Collaborators
Kenneth Aldape
National Cancer Institute
Co-authored papers
11
Gabriel N Hortobagyi
The University of Texas MD Anderson Cancer Center
Co-authored papers
11
William F Symmans
Co-authored papers
10
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers
10
Naoto T Ueno
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Co-authored papers
9
Thomas A Buchholz
Co-authored papers
8
Xiongjun Wang
Guangzhou University
Co-authored papers
7
Funda Meric-Bernstam
University of Texas MD Anderson Cancer Center
Co-authored papers
6
Lajos Pusztai
Co-authored papers
5
Jun Qin
Co-authored papers
5
Hua Yu
Guangzhou University
Co-authored papers
4
Lavinia P Middleton
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Sung Yun Jung
Co-authored papers
4
Paula I Gonzalez-Ericsson
Co-authored papers
3
Tony Hunter
Salk Institute for Biological Studies
Co-authored papers
3
Christos Sotiriou
Co-authored papers
3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers
3
Sandra Demaria
Weill Cornell Medical College
Co-authored papers
3
John M S Bartlett
University of Edinburgh
Co-authored papers
3
David A Moore
University College London Cancer Institute
Co-authored papers
3
James M Reuben
The University of Texas MD Anderson Cancer Center
Co-authored papers
3
David L Rimm
Yale University School of Medicine
Co-authored papers
3
Abenaa M Brewster
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers
2
Hannah Y Wen
Memorial Sloan Kettering Cancer Center
Co-authored papers
2
Paul J van Diest
University Medical Center Utrecht
Co-authored papers
2
Thomas Walter
PSL University
Co-authored papers
2
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers
2
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers
2
Rong Zeng
Co-authored papers
2
1 - 30